Innophos Holdings, Inc Logo

Print Print page | Email Email page | PDF Download PDF | Add to Briefcase Add to briefcase
« Previous Release | Next Release »



Innophos Board Of Directors Appoints Dr. Kim Ann Mink As Chairman Of The Board

CRANBURY, N.J., Feb. 21, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, announced today that its Board of Directors has elected CEO and President Dr. Kim Ann Mink to serve in the additional role of Chairman of the Board of Directors, effective today. She has served as CEO and President since joining the Company in December 2015. Gary Cappeline, Operating Partner of AEA Investors LLC, will continue to serve as Lead Independent Director.

"Kim Ann's strong sense of purpose, strategic leadership and business insight along with her commitment to sound corporate governance make her immensely qualified to assume the role of Chairman," Mr. Cappeline said.  "During her tenure as CEO, she has built a top-notch leadership team, developed a strategic roadmap for the future direction of the company, and made excellent progress on our operational and commercial excellence initiatives. I am very confident in Kim Ann's ability to lead the company's transformation. She is clearly the leader for Innophos' future and has the unanimous support of the board of directors.  We are excited to be working with her."

"I am truly appreciative of the Board's vote of confidence and deeply honored by this appointment," Dr. Mink said. "I value the opportunity to work with the Board and our talented employees to transform Innophos into a market-oriented growth company that provides a broad set of value-added, innovative and technology-based ingredient solutions. I am confident we will continue to deliver value to our shareholders and customers."

About Kim Ann Mink
Kim Ann Mink, Ph.D. has been the Chief Executive Officer and President of Innophos since December 2015 and a director of Innophos since February 2016. Prior to joining Innophos, she served as Business President of Elastomers, Electrical and Telecommunications at The Dow Chemical Company, or Dow Chemical, from September 2012 to December 2015. Dr. Mink joined Dow Chemical in April 2009 as Global General Manager, Performance Materials and President and Chief Executive Officer of ANGUS Chemical Co. (then a fully owned subsidiary of Dow Chemical). Prior to joining Dow Chemical, Dr. Mink was Corporate Vice President and Global General Manager, Ion Exchange Resins at the Rohm and Haas Company (now a fully owned subsidiary of Dow Chemical), where she spent more than 20 years serving in numerous senior roles with increasing responsibilities. From September 2012 to December 2015, Dr. Mink served as a member of the Board of Advisors of Catalyst Inc. From November 2012 to December 2016, she served as a member of the National Board of Trustees of the ALS Association. In addition, in 2014, Dr. Mink was named to STEMconnector's 100 Diverse Corporate Leaders in STEM. Dr. Mink received her B.A. in Chemistry from Hamilton College and a Ph.D. in Analytical Chemistry from Duke University. She is a graduate of the Wharton School of Business Management Program.

About Gary Cappeline
Gary Cappeline is currently the Lead Independent Director on the Innophos Board of Directors. Mr. Cappeline currently serves as an Operating Partner of AEA Investors LLC, a private equity investment fund. Before joining AEA in 2007, Mr. Cappeline was president and chief operating officer of Ashland Inc., a diversified company, to which he returned in 2002 after service as a senior executive in the chemical sectors at Engelhard Corporation and Honeywell International. He also served as chemical industry partner at Bear Stearns Merchant Bank. Mr. Cappeline currently serves on the board of directors of Evoqua Water Technologies (a manufacturer of water purification equipment) and Swanson Industries (as chairman) (a mining equipment repair business). He previously served as a board and executive committee member of the American Chemistry Council (a chemical industry trade association); a director of Unifrax Corporation (a manufacturer of high temperature insulation products); chairman and a director of Houghton International Inc. (a manufacturer of metal working fluids); a director of Shoes for Crews, LLC (a manufacturer of slip resistant footwear); a director of RelaDyne Inc. (a distributor of lubricants and fuels); and a director of Tampico Beverages Inc. (a manufacturer of fruit drinks). Mr. Cappeline earned BS and MS degrees in chemical engineering from the City College of New York.

About Innophos
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com. 'IPHS-G'

Safe Harbor for Forward-Looking and Cautionary Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, actual results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.

Contacts

Investors: Mark Feuerbach, 609-366-1204 or investor.relations@innophos.com

Media: Ryan Flaim, Sharron Merrill Associates, 617-542-5300 or IPHS@investorrelations.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innophos-board-of-directors-appoints-dr-kim-ann-mink-as-chairman-of-the-board-300410729.html

SOURCE Innophos Holdings, Inc.

News Provided by Acquire Media

Close window | Back to top